Virtus Investment Advisers, Inc. Amphastar Pharmaceuticals, Inc. Call Options Transaction History
Virtus Investment Advisers, Inc.
- $119 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
263Shares Held
34MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$149 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$68.2 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.6 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.1 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$34.5 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.23B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...